Search research articles
Contact Us
Filters
Showing results (41-50 of 271) with videos related to
Page
of 28
Sort By:
Bioconjugate Chemistry
|
September 1, 1996
Characterization of RFB4-Pseudomonas exotoxin A immunotoxins targeted to CD22 on B-cell malignancies
E Mansfield, I Pastan, D J FitzGerald
Annual Review of Biochemistry
|
January 1, 1992
Recombinant toxins as novel therapeutic agents
I Pastan, V Chaudhary, D J FitzGerald
Mutagenesis
|
July 1, 1989
Detection of non-genotoxic carcinogens in the BALB/c 3T3 cell transformation/mutation assay system
D J Fitzgerald, C Piccoli, H Yamasaki
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1987
Pseudomonas exotoxin coupled to a monoclonal antibody against ovarian cancer inhibits the growth of human ovarian cancer cells in a mouse model
M C Willingham, D J FitzGerald, I Pastan
The Journal of Urology
|
June 1, 1993
A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer
C P Theuer, D J FitzGerald, I Pastan
Biochemical and Biophysical Research Communications
|
October 31, 1991
A proper amino terminus of diphtheria toxin is important for cytotoxicity
V K Chaudhary, D J FitzGerald, I Pastan
Molecular Microbiology
|
November 1, 1996
Pseudomonas exotoxin exhibits increased sensitivity to furin when sequences at the cleavage site are mutated to resemble the arginine-rich loop of diphtheria toxin
M F Chiron, M Ogata, D J FitzGerald
The Journal of Clinical Investigation
|
November 1, 1988
Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis
D J Fitzgerald, J Fragetta, G A FitzGerald
Seminars in Cancer Biology
|
October 1, 1990
Selective killing of tumor cells using EGF or TGF alpha-Pseudomonas exotoxin chimeric molecules
C B Siegall, D J FitzGerald, I Pastan
Blood
|
March 15, 1992
Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction
S Kunitada, G A FitzGerald, D J Fitzgerald
Page
of 28
Search research articles
Search
Showing results (41-50 of 271) with videos related to
Sort By:
Page
of 28
Bioconjugate Chemistry
|
September 1, 1996
Characterization of RFB4-Pseudomonas exotoxin A immunotoxins targeted to CD22 on B-cell malignancies
E Mansfield, I Pastan, D J FitzGerald
Annual Review of Biochemistry
|
January 1, 1992
Recombinant toxins as novel therapeutic agents
I Pastan, V Chaudhary, D J FitzGerald
Mutagenesis
|
July 1, 1989
Detection of non-genotoxic carcinogens in the BALB/c 3T3 cell transformation/mutation assay system
D J Fitzgerald, C Piccoli, H Yamasaki
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1987
Pseudomonas exotoxin coupled to a monoclonal antibody against ovarian cancer inhibits the growth of human ovarian cancer cells in a mouse model
M C Willingham, D J FitzGerald, I Pastan
The Journal of Urology
|
June 1, 1993
A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer
C P Theuer, D J FitzGerald, I Pastan
Biochemical and Biophysical Research Communications
|
October 31, 1991
A proper amino terminus of diphtheria toxin is important for cytotoxicity
V K Chaudhary, D J FitzGerald, I Pastan
Molecular Microbiology
|
November 1, 1996
Pseudomonas exotoxin exhibits increased sensitivity to furin when sequences at the cleavage site are mutated to resemble the arginine-rich loop of diphtheria toxin
M F Chiron, M Ogata, D J FitzGerald
The Journal of Clinical Investigation
|
November 1, 1988
Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis
D J Fitzgerald, J Fragetta, G A FitzGerald
Seminars in Cancer Biology
|
October 1, 1990
Selective killing of tumor cells using EGF or TGF alpha-Pseudomonas exotoxin chimeric molecules
C B Siegall, D J FitzGerald, I Pastan
Blood
|
March 15, 1992
Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction
S Kunitada, G A FitzGerald, D J Fitzgerald
Page
of 28